Related Articles
c‑Jun and FOXO1 mediate the expression of oncogenic PKC‑ι in human prostate cancer cells with an interplay between NF‑κB, IL‑8 and ICAM‑1
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
Inhibition of atypical protein kinase C‑ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
Analysis of PKC‑ζ protein levels in normal and malignant breast tissue subtypes
Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats